Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial
- PMID: 20852060
- PMCID: PMC3065299
- DOI: 10.1161/CIRCHEARTFAILURE.110.958785
Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial
Abstract
Background: Heart failure (HF) with preserved left ventricular ejection fraction (HFPEF) is the most common form of HF in the older population. Exercise intolerance is the primary chronic symptom in patients with HFPEF and is a strong determinant of their reduced quality of life (QOL). Exercise training (ET) improves exercise intolerance and QOL in patients with HF with reduced ejection fraction (EF). However, the effect of ET in HFPEF has not been examined in a randomized controlled trial.
Methods and results: This 16-week investigation was a randomized, attention-controlled, single-blind study of medically supervised ET (3 days per week) on exercise intolerance and QOL in 53 elderly patients (mean age, 70±6 years; range, 60 to 82 years; women, 46) with isolated HFPEF (EF ≥50% and no significant coronary, valvular, or pulmonary disease). Attention controls received biweekly follow-up telephone calls. Forty-six patients completed the study (24 ET, 22 controls). Attendance at exercise sessions in the ET group was excellent (88%; range, 64% to 100%). There were no trial-related adverse events. The primary outcome of peak exercise oxygen uptake increased significantly in the ET group compared to the control group (13.8±2.5 to 16.1±2.6 mL/kg per minute [change, 2.3±2.2 mL/kg per minute] versus 12.8±2.6 to 12.5±3.4 mL/kg per minute [change, -0.3±2.1 mL/kg per minute]; P=0.0002). There were significant improvements in peak power output, exercise time, 6-minute walk distance, and ventilatory anaerobic threshold (all P<0.002). There was improvement in the physical QOL score (P=0.03) but not in the total score (P=0.11).
Conclusions: ET improves peak and submaximal exercise capacity in older patients with HFPEF.
Trial registration: ClinicalTrials.gov NCT01113840.
Figures
References
-
- Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: Evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol. 1993;22:3A–5A. - PubMed
-
- Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973–1986. Evidence for increasing population prevalence. Arch Intern Med. 1990;150:769–773. - PubMed
-
- Kitzman DW, Gardin JM, Gottdiener JS, Arnold AM, Boineau R, Aurigemma GP, Marino E, Lyles M, Cushman M, Enright P. Importance of heart failure with preserved systolic function in patients > or = 65 Years of Age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87:413–419. - PubMed
-
- Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R, Fabitz RR, Howard BV. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol. 2000;86:1090–1096. - PubMed
-
- Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282–2289. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous